Attitudes of patients and family members towards implantable psychiatric medication

被引：6

作者：

Dankert, Mary E. ^{[2
]}

Brensinger, Colleen M. ^{[3
]}

Metzger, Kayla L. ^{[2
]}

Li, Chunbo ^{[4
]}

Koleva, Svetlinka G. ^{[5
]}

Mesn, Andrea ^{[6
]}

Laprade, Batrice ^{[6
]}

Wiguna, Tjhin ^{[7
]}

Han, Changsu ^{[8
]}

Farooq, Saeed ^{[9
]}

Severusi, W. Emanuel ^{[10
]}

GayareS, Jocelyn G. ^{[11
]}

Langosch, Jens M. ^{[12
]}

Lallart, Xavier ^{[13
]}

Tateno, Masaru ^{[14
]}

Mihai, Adriana ^{[15
]}

Nair, Sudha R. N. ^{[16
]}

Belmaker, Robert ^{[17
]}

Rybakowski, Janusz ^{[18
]}

Owe-Larsson, Bjoern ^{[19
]}

Kane, John M. ^{[20
]}

Johnstone, Eve C. ^{[21
]}

Maclntyre, Donald J. ^{[21
]}

Malhotra, Sameer

Gonzdlez-Pinto, Ana ^{[22
]}

Mosquera, Fernando ^{[22
]}

Babb, Suzann M. ^{[23
]}

Pour, Ehsan Habib ^{[24
]}

Fatemi, Seyedeh Sedigheh ^{[24
]}

Swanson, Charles ^{[25
]}

Adler, Caleb ^{[26
]}

Young, Allan ^{[27
]}

Hoeft, Fumiko ^{[28
]}

Sivakumar, Kandiah

Radoeva, Petya D.

Lallart, Elise A.

Bilker, Warren B. ^{[3
]}

Siegel, Steven J. ^{[1
,2
]}

机构：

[1] Univ Penn, Dept Psychiat, Translat Res Labs, Stanley Ctr Expt Therapeut Psychiat,Div Neuropsyc, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Psychiat, Div Neuropsychiat, Philadelphia, PA 19104 USA

[3] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA

[4] Tongji Univ, Tongji Hosp, Dept Psychiat, Shanghai 200092, Peoples R China

[5] Hosp Sofia City, Sofia, Bulgaria

[6] Ctr Neuropsychiat Studies Costa Rica, ACENP Costa Rica, San Jose, Costa Rica

[7] Univ Indonesia, Dept Psychiat, Jakarta, Indonesia

[8] Korea Univ, Ansan Hosp, Coll Med, Dept Psychiat, Ansan, South Korea

[9] Lady Reading Hosp, Postgrad Med Inst, Dept Psychiat, Peshawar, Pakistan

[10] Univ Munich, Dept Psychiat, D-8000 Munich, Germany

[11] Univ St La Salle, Coll Med, Dept Psychiat, Bacolod City, Philippines

[12] Univ Freiburg, Dept Psychiat, Freiburg, Germany

[13] Hosp Ville Evrard, Paris, France

[14] Sapporo Med Univ, Dept Neuropsychiat, Sapporo, Hokkaido, Japan

[15] Univ Med & Pharm, Dept Psychiat, Targu Mures, Romania

[16] CareLink Community Support Serv, Norristown, PA USA

[17] Ben Bur Univ Negev, Beer Sheva, Israel

[18] Univ Med Sci, Dept Adult Psychiat, Poznan, Poland

[19] Karolinska Univ Hosp Huddinge, Dept Psychiat, Stockholm, Sweden

[20] Long Isl Jewish Med Ctr, Zucker Hillside Hosp, Glen Oaks, NY USA

[21] Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland

[22] Hosp Santiago, Dept Psychiat, Vitoria, Spain

[23] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA

[24] Mashhadd Univ Med Sci, Mashhad, Iran

[25] Univ Alabama, Birmingham, AL USA

[26] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA

[27] Newcastle Univ, Dept Psychiat, Newcastle Upon Tyne, Tyne & Wear, England

[28] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA

来源：

SCHIZOPHRENIA RESEARCH | 2008年 / 105卷 / 1-3期

关键词：

Medication; Psychiatry; Attitude; Schizophrenia; Adherence; Family; Drug implant;

D O I：

10.1016/j.schres.2008.05.008

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Introduction: Medication is a necessary part of treatment for severe psychiatric illnesses such as schizophrenia and nonadherence to prescribed medication is one of the most important public health issues in psychiatry today. The devastating consequences of nonadherence have motivated the development of novel therapeutic strategies, including a new long-term implantable medication delivery system. Methods: The current study assesses attitudes towards implantable medication in psychiatric patients and their family members. Patients included in the study had diagnoses of Schizophrenia, Schizoaffective Disorder, Mood or Anxiety related disorders. Results: 49.62% of patients and 74.47% of family members endorse support for implantable medication. Conclusions: This study demonstrates that implants may be an acceptable alternative to oral and injectable medication for a subset of psychiatric patients and their families. (C) 2008 Elsevier B.V. All rights reserved.

引用

页码：279 / 286

页数：8

共 28 条

[1] PREDICTING MEDICATION COMPLIANCE IN A PSYCHOTIC POPULATION
ADAMS, SG
HOWE, JT
[J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1993, 181 (09) : 558 - 560
[2] [Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[3] Archer DF, 2002, FERTIL STERIL, V77, pS27
[4] Response rates to mail surveys published in medical journals
Asch, DA
Jedrziewski, MK
Christakis, NA
[J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (10) : 1129 - 1136
[5] Six-month outcome following a relapse of schizophrenia
Bergen, J
Hunt, G
Armitage, P
Bashir, M
[J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1998, 32 (06) : 815 - 822
[6] Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments
Bosveld-van Haandel, LJM
Slooff, CJ
van den Bosch, RJ
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 2001, 103 (05) : 335 - 346
[7] REASONS FOR ADMISSION AMONG 6 PROFILE SUBGROUPS OF RECIDIVISTS OF INPATIENT SERVICES
CASPER, ES
REGAN, JR
[J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1993, 38 (10): : 657 - 661
[8] Compliance with medication regimens for mental and physical disorders
Cramer, JA
Rosenheck, R
[J]. PSYCHIATRIC SERVICES, 1998, 49 (02) : 196 - 201
[9] Pilot study of the effectiveness of the family-to-family education program
Dixon, L
Stewart, B
Burland, J
Delahanty, J
Lucksted, A
Hoffman, M
[J]. PSYCHIATRIC SERVICES, 2001, 52 (07) : 965 - 967
[10] Fox C, 1996, J Health Soc Policy, V8, P39, DOI 10.1300/J045v08n01_04

← 1 2 3 →